Investigating the effect of high dose statin on cardivascular complications in patients who underwent noncardiac surgery

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20240825062861N1

Enrollment

140

Registered

2024-09-03

Start date

2024-09-07

Completion date

Unknown

Last updated

2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Cardiac arrhythmia. Condition 2: Heart failure. Condition 3: cardiac arrest. Cardiac arrhythmia, unspecified Other postprocedural cardiac functional disturbances Postprocedural cardiac arrest following other surgery

Interventions

Intervention 1: Intervention group: participants in the intervention group will receive high-dose statin (80 mg of atorvastatin orally) before surgery. Intervention 2: Control group: Participants in t

Eligibility

Sex/Gender

All

Age

45 Years to 90 Years

Inclusion criteria

Inclusion criteria: Patients who has non-cardiac surgery the risk of their surgery is moderate or high are in the age range of 45 to 90 years.

Exclusion criteria

Exclusion criteria: surgery is canceled for any reason history of taking statins before ESRD

Design outcomes

Primary

Measure	Time frame
Highly sensitive Troponin. Timepoint: before and after surgery. Method of measurement: clinical lab.	—

Secondary

Measure	Time frame
Cardiac death. Timepoint: Days after surgery. Method of measurement: patient visit.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAbolfazl Mohsenizade

Artesh University of Medical Sciences

dr.mohseni959@gmail.com+98 21 8609 6350

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026